Quest Allegedly Sold Defective Lab Kits Causing Thousands to Have Unnecessary Surgery

According to a class action suit, a Quest Diagnostics subsidiary allegedly sold defective hormone tests. These tests may have led to thousands of unnecessary surgeries and hundreds of millions of dollars in damages.

Courthouse News reports:

 

“... Quest bought Nichols Institute Diagnostics in the mid-1990s after the company created an automated test to measure parathyroid hormone levels ... parathyroid gland failure is a common complication of severe kidney disease.”

 

If Parathyroid levels are mistakenly believed to be too low, doctors will prescribe high doses of vitamin D drugs. This can lead to the calcification of blood vessels and soft tissues, a problem that can be deadly.

+ Sources and References
Click Here and be the first to comment on this article
Post your comment